Abstract

Medicinal plants and their extracts have been used as important sources for drug discovery. In particular, plant-derived natural compounds, including phytochemicals, antioxidants, vitamins, and minerals, are gaining attention as they promote health and prevent disease. Although several in vitro methods have been developed to confirm the biological activities of natural compounds, there is still considerable room to reduce time and cost. To overcome these limitations, several in silico methods have been proposed for conducting large-scale analysis, but they are still limited in terms of dealing with incomplete and heterogeneous natural compound data. Here, we propose a deep learning-based approach to identify the medicinal uses of natural compounds by exploiting massive and heterogeneous drug and natural compound data. The rationale behind this approach is that deep learning can effectively utilize heterogeneous features to alleviate incomplete information. Based on latent knowledge, molecular interactions, and chemical property features, we generated 686 dimensional features for 4,507 natural compounds and 2,882 approved and investigational drugs. The deep learning model was trained using the generated features and verified drug indication information. When the features of natural compounds were applied as input to the trained model, potential efficacies were successfully predicted with high accuracy, sensitivity, and specificity.

Highlights

  • A large number of medicinal plants possess diverse natural compounds, contributing to drug development by providing novel candidate therapeutic agents against various diseases

  • We propose a deep learning-based approach to predict the medicinal uses of natural compounds

  • Natural compounds have received considerable attention as an important resource for the development of drugs and dietary supplements owing to the increasing evidence of their health-promoting effects

Read more

Summary

Introduction

A large number of medicinal plants possess diverse natural compounds, contributing to drug development by providing novel candidate therapeutic agents against various diseases. Knowledge-based approaches apply statistical analysis to scientific databases, such as PubMed, or clinical trial information to identify medicinal natural compound candidates for a certain disease (Butler, 2005; Jensen et al, 2014; Shergis et al, 2015). These approaches provide better coverage compared with molecular and chemical-based approaches, but their performance is low because they cannot directly consider complex molecular mechanisms and chemical structures. We need to solve the problem with the bottleneck effect caused by the limited natural compound information and inappropriate methods available currently

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call